Viive M. Howell

Bill Walsh Translational Cancer Research Laboratory, Royal North Shore Hospital, University of Sydney

Affiliated withRoyal North Shore Hospital, University of Sydney

Research Area

Biography

Viive M. Howell has not added Biography.
If you are Viive M. Howell and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 2	2015

Other Publications

Article	Year
A molecular diagnosis of hyperparathyroidism-jaw tumor syndrome in an adolescent with recurrent kidney stones. The Journal of pediatrics\| PubMed ID: 15480389	2004
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer research\| PubMed ID: 15492263	2004
Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hy... The American journal of surgical pathology\| PubMed ID: 16931959	2006
Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism. The Journal of molecular diagnostics : JMD\| PubMed ID: 17065424	2006
Evidence for a direct role of the disease modifier SCNM1 in splicing. Human molecular genetics\| PubMed ID: 17656373	2007
A targeted deleterious allele of the splicing factor SCNM1 in the mouse. Genetics\| PubMed ID: 18791226	2008
Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. The Journal of clinical endocrinology and metabolism\| PubMed ID: 19017757	2009
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocrine-related cancer\| PubMed ID: 20026646	2010
The use of denaturing high performance liquid chromatography (DHPLC) for mutation scanning of hereditary cancer genes. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 20721741	2010
Sleeping beauty--a mouse model for all cancers? Cancer letters\| PubMed ID: 22079740	2012
Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction. Hypertension\| PubMed ID: 22508833	2012
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC cancer\| PubMed ID: 23272653	2012
Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes. Expert opinion on medical diagnostics\| PubMed ID: 23489357	2007
Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 23533276	2013
Correlation of MicroRNA 132 Up-regulation with an Unfavorable Clinical Outcome in Patients with Primary Glioblastoma Multiforme Treated with Radiotherapy Plus Concomitant and Adjuvant Temozo... Translational oncology\| PubMed ID: 24466377	2013
Genetically engineered mouse models for epithelial ovarian cancer: are we there yet? Seminars in cell & developmental biology\| PubMed ID: 24685617	2014
Mice and men working together for over 100 years in the fight against cancer. Seminars in cell & developmental biology\| PubMed ID: 24704434	2014
From mice to men: GEMMs as trial patients for new NSCLC therapies. Seminars in cell & developmental biology\| PubMed ID: 24718320	2014
Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines. Cancer immunology research\| PubMed ID: 24795359	2014
Genetically engineered insertional mutagenesis in mice to model cancer: Sleeping Beauty. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 25064115	2014
Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma. Scientific reports\| PubMed ID: 25141917	2014
Genomic alterations as mediators of miRNA dysregulation in ovarian cancer. Genes, chromosomes & cancer\| PubMed ID: 25280227	2015
Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines. Proteomics. Clinical applications\| PubMed ID: 25755195	2015
Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors. Hormones & cancer\| PubMed ID: 25943777	2015